SCHEMBL2290701

SCHEMBL2290701

Cc1cccc(C)c1OCc1cc(C(C)(C)C)ccc1C=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 1/20 0.38
SCN2A Q99250 2/20 0.36
MAPT P10636 5/20 0.35
ALDH1A1 P00352 4/20 0.35
POLB P06746 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MAPK1 P28482 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
CDK4 P11802 2/20 0.35
CCND1 P24385 2/20 0.35
SCN8A Q9UQD0 2/20 0.34
CCNB2 O95067 1/20 0.34
CDK1 P06493 1/20 0.34
CCNB1 P14635 1/20 0.34
CCNB3 Q8WWL7 1/20 0.34
TSHR P16473 2/20 0.34
KDM4E B2RXH2 1/20 0.34
TDP1 Q9NUW8 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2289740 0.90 SCN8A (0.36) MRGPRX4SCN2AMAPTALDH1A1POLB
SCHEMBL2292582 0.85 ALDH1A1 (0.33) SCN2AMAPTALDH1A1POLBMEN1
SCHEMBL2287477 0.84 MRGPRX4 (0.35) MRGPRX4SCN2AMAPTALDH1A1POLB
SCHEMBL2293209 0.84 SCN4A (0.38) SCN2AMAPTALDH1A1POLBMEN1
SCHEMBL2293617 0.80 TRIM24 (0.49) MAPTALDH1A1POLBMEN1KMT2A
SCHEMBL2291217 0.79 SCN2A (0.39) MRGPRX4SCN2AMAPTALDH1A1POLB
SCHEMBL2291848 0.79 THRA (0.38) MRGPRX4SCN2AMAPTALDH1A1POLB
SCHEMBL1201073 0.78 ERN1 (0.41) MAPTALDH1A1POLBMEN1KMT2A
SCHEMBL2289750 0.78 CCNB2 (0.40) MAPTALDH1A1POLBMEN1KMT2A
SCHEMBL1539474 0.78 CDK4 (0.50) ALDH1A1MEN1KMT2ASMN1; SMN2CDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2149545-B1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND SUMITOMO CHEMICAL CO (JP) 2016-10-05 EP disclosed
US-7994367-B2 Method for producing benzaldehyde compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-08-09 US disclosed
US-20100210879-A1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-08-19 US disclosed
EP-2149545-A1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND Sumitomo Chemical Company, Limited (JP) 2010-02-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100210879-A1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND NQO1, C9, TRPA1 MRGPRX4 282/4885SCN2A 1208/4885MAPT 3284/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.